Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve
- 1 March 1993
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 168 (3), 787-792
- https://doi.org/10.1016/s0002-9378(12)90820-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform moleThe Lancet, 1990
- Hormonal contraception and trophoblastic sequelae after hydatidiform mole (A Gynecologic Oncology Group study)American Journal of Obstetrics and Gynecology, 1989
- Initial management of hydatidiform moleAmerican Journal of Obstetrics and Gynecology, 1988
- Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasiaGynecologic Oncology, 1988
- HYDATIDIFORM MOLE IN ENGLAND AND WALES 1973-83The Lancet, 1986
- Comparison of the Analytical Characteristics and Clinical Usefulness in Tumour Monitoring of Fifteen hCG(-β) Immunoassay KitsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1985
- The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curveAmerican Journal of Obstetrics and Gynecology, 1985
- Natural history of hydatidiform mole after primary evacuationAmerican Journal of Obstetrics and Gynecology, 1983
- Clinical and laboratory correlates of molar pregnancy and trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1977
- A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormoneAmerican Journal of Obstetrics and Gynecology, 1972